Serum GGT
1 paper1 finding
- Humans1
Associations
1Pancreatobiliary cancer
upin humans1HR 1.554
1 study
Pancreatobiliary cancer
upin humans1HR 1.554
Serum GGT raises the risk of pancreatobiliary cancer in humans (HR 1.554 for quartile 4 vs quartile 1, p < 0.001).
“The adjusted hazard ratio for pancreatobiliary cancer in quartiles 2-4 compared with that in quartile 1 was 1.091, 1.223, and 1.554, respectively, demonstrating a significant upward trend (p < 0.001).”
Humansdiabetes mellitus7.2 years
ADA Scientific Sessions 2025 abstract13 Jun 2025
Latest
Journal of Cachexia, Sarcopenia and Muscle
Elevated Serum Gamma-Glutamyl Transferase as a Risk Factor for Frailty in Older Men: A Nationwide Population-Based Study
Study in peopleBiomarkers
ADA Scientific Sessions 2025 Abstract
Association between Gamma-glutamyl Transferase Levels and Pancreatobiliary Cancer Risk in Diabetes—Evidence from the National Health Insurance Cooperation Health Checkup 2009–2012
Cohort study in peopleBiomarkers